PETALING JAYA: Sinovac Covid-19 vaccines (SV) are expected to boost Pharmaniaga Bhd’s earnings in the coming quarters mainly from the private sector and exports.
CGS-CIMB Research has raised its financial year 2021 (FY21) forecast on Pharmaniaga earnings by 4% and another 3% in FY22.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!